On the Technology Development team, Lucas is focused on advancing RNA-guided nucleases (RGNs) and base editor technologies, spearheading protein engineering campaigns to elevate Life Edit's therapeutic capabilities. He has over 15 years of experience employing cutting-edge protein engineering strategies to craft groundbreaking enzymes and therapeutic proteins.
Prior to joining the Life Edit Therapeutics team, Lucas held the role of Protein Engineering Scientist at the New Mexico Consortium. In this capacity, he directed his expertise toward engineering proteases and chimeric proteins, focusing on their applications in treating human and plant diseases. Additionally, Lucas dedicated four years to his role as a post-doctoral scientist at Johns Hopkins University, where he focused on devolving switch behavior on Transcription activator-like effectors (TALE) and Cas9 proteins to function as artificial repressors with genetic engineering applications.
Lucas earned his PhD in Biochemistry from The University of São Paulo, Medical School, Brazil.